Overview of HIV
- PMID:18541903
- DOI: 10.1097/PSY.0b013e31817ae69f
Overview of HIV
Abstract
This article provides an overview and reviews the HIV pandemic, the basic biology and immunology of the virus (e.g., genetic diversity of HIV and the viral life cycle), the phases of disease progression, modes of HIV transmission, HIV testing, immune response to the infection, and current therapeutic strategies. HIV is occurring in epidemic proportions, especially in Sub-Saharan Africa. In the US, men who have sex with men account for over half of AIDS diagnoses; racial and ethnic minorities are disproportionally affected. Factors influencing the progression and severity of HIV infection include type of immune response, coinfection (e.g., another sexually transmitted infection, including hepatitis B or C), age and behavioral and psychosocial factors. Antiretroviral therapies can achieve reduction in blood levels of the HIV virus below the limits of detection by current technology. However, effective treatment requires adherence to therapy. Patient failure to adhere to treatment regimens results in detectible circulating virus and in HIV disease progression, and is the primary cause of drug resistance. In addition to research on the immunology and virology of the disease, other studies focus on behavioral and psychosocial factors that may affect medication adherence and risk behaviors.
Similar articles
- [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].Panel de expertos de Gesida y Plan Nacional sobre el Sida.Panel de expertos de Gesida y Plan Nacional sobre el Sida.Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Epub 2009 Feb 26.Enferm Infecc Microbiol Clin. 2009.PMID:19246124Spanish.
- Co-occurrence of treatment nonadherence and continued HIV transmission risk behaviors: implications for positive prevention interventions.Kalichman SC.Kalichman SC.Psychosom Med. 2008 Jun;70(5):593-7. doi: 10.1097/PSY.0b013e3181773bce. Epub 2008 Jun 2.Psychosom Med. 2008.PMID:18519882
- A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy.Bezemer D, de Wolf F, Boerlijst MC, van Sighem A, Hollingsworth TD, Prins M, Geskus RB, Gras L, Coutinho RA, Fraser C.Bezemer D, et al.AIDS. 2008 May 31;22(9):1071-7. doi: 10.1097/QAD.0b013e3282fd167c.AIDS. 2008.PMID:18520351
- Tuberculosis and other clinical presentation of HIV/AIDS in patients with or without undergoing antiretroviral therapy in Kathmandu.Dhungana GP, Ghimire P, Sharma S, Rijal BP.Dhungana GP, et al.Kathmandu Univ Med J (KUMJ). 2007 Jan-Mar;5(1):22-6.Kathmandu Univ Med J (KUMJ). 2007.PMID:18603981
- Advances in HIV/AIDS therapy.Johnson SC, Gerber JG.Johnson SC, et al.Adv Intern Med. 2000;45:1-40.Adv Intern Med. 2000.PMID:10635044Review.
Cited by
- Immunological and molecular assessment of HIV-1 mutations for antiretroviral drug resistance in Saudi Arabia.El-Daly MM, Zaher KA, Zaki EA, Bajrai LH, Alhazmi MM, Abdulhaq A, Azhar EI.El-Daly MM, et al.PLoS One. 2024 Jun 26;19(6):e0304408. doi: 10.1371/journal.pone.0304408. eCollection 2024.PLoS One. 2024.PMID:38923958Free PMC article.
- Using the Millon Behavioral Medicine Diagnostic (MBMD) to evaluate the need for mental health services in association with biomarkers of disease status among HIV positive men and women.Burbridge C, Cruess DG, Antoni MH, Meagher S.Burbridge C, et al.J Clin Psychol Med Settings. 2011 Mar;18(1):30-8. doi: 10.1007/s10880-011-9231-x.J Clin Psychol Med Settings. 2011.PMID:21340710
- The assessment of complementary and alternative medicine use among individuals with HIV: a systematic review and recommendations for future research.Owen-Smith A, DePadilla L, DiClemente R.Owen-Smith A, et al.J Altern Complement Med. 2011 Sep;17(9):789-96. doi: 10.1089/acm.2010.0669.J Altern Complement Med. 2011.PMID:21875350Free PMC article.Review.
- Atazanavir: a review of its use in the management of HIV-1 infection.Croom KF, Dhillon S, Keam SJ.Croom KF, et al.Drugs. 2009 May 29;69(8):1107-40. doi: 10.2165/00003495-200969080-00009.Drugs. 2009.PMID:19496633Review.
- The level of DING proteins is increased in HIV-infected patients: in vitro and in vivo studies.Djeghader A, Aragonès G, Darbinian N, Elias M, Gonzalez D, García-Heredia A, Beltrán-Debón R, Kaminski R, Gotthard G, Hiblot J, Rull A, Rohr O, Schwartz C, Alonso-Villaverde C, Joven J, Camps J, Chabriere E.Djeghader A, et al.PLoS One. 2012;7(3):e33062. doi: 10.1371/journal.pone.0033062. Epub 2012 Mar 9.PLoS One. 2012.PMID:22427948Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical